Carolina Journal by Video - CXXI: Locke’s Mitch Kokai analyzes the latest Leandro school funding developments | Eastern NC Now

The Carolina Journal makes a wide sweeping evaluation of the news that most effects us here in North Carolina, and is distilled, here on BCN, for your clear understanding by the electronic means of video broadcast.

ENCNow
    Publisher's Note: Publisher's Note: This post appears here courtesy of the Carolina Journal. Presented in this Carolina Journal video broadcast is Mitch Kokai.

    The Carolina Journal makes a wide sweeping evaluation of the news that most effects us here in North Carolina, and is distilled, here on BCN, for your clear understanding by the electronic means of video broadcast.



    Mitch Kokai, John Locke Foundation senior political analyst, discusses the latest developments in North Carolina’s Leandro school funding lawsuit. Kokai offered these comments during the April 13, 2022, edition of Spectrum News 1’s “Capital Tonight.”

    Publisher's note: If you find these video vignettes informative, you can find all of the Carolina Journal TV videos here.
Go Back


Leave a Guest Comment

Your Name or Alias
Your Email Address ( your email address will not be published )
Enter Your Comment ( text only please )




Why Won’t North Carolina Democrats Denounce Biden as He Visits Tarheel State? Carolina Journal, Editorials, Op-Ed & Politics Millions in Hurricane Florence relief money remains untracked


HbAD0

Latest Op-Ed & Politics

this will help populist anti-immigration right in next year's presidential election
Unloaded on President Donald Trump in a series of profanity-laced private text messages

HbAD1

The tour bus will make 63 stops across 13 states across the country, and will end on Election Day in November.

HbAD2

the need for a pro-America curriculum in our schools
Organizations are quietly using foreign money to move the needle toward their preferred political outcomes.
illegal alien "asylum seeker" migrants are a crime wave on both sides of the Atlantic

HbAD3

 
 
Back to Top